Tumor necrosis factor α and nucleus-pulposus-induced nerve root injury

Spine

Volumn 23, Issue 23, 1998, Pages 2538-2544

  Olmarker, Kjell ^a   Larsson, Karin ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cells; Disc herniation; Intervertebral disc; Low back pain; Nerve root; Nucleus pulposus; Sciatica; Tumor necrosis factor

Indexed keywords

DOXYCYCLINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; ISCHIALGIA; NERVE CONDUCTION; NERVE ROOT INJURY; NONHUMAN; NUCLEUS PULPOSUS; PRIORITY JOURNAL; SWINE;

ANIMALS; ANTIBODIES, MONOCLONAL; CAUDA EQUINA; CELL TRANSPLANTATION; CELLS, CULTURED; DOXYCYCLINE; GANGLIA, SPINAL; IMMUNOENZYME TECHNIQUES; INTERVERTEBRAL DISK; LUMBAR VERTEBRAE; NEURAL CONDUCTION; SWINE; THORACIC VERTEBRAE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032411612     PISSN: 03622436     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007632-199812010-00008     Document Type: Article

References (70)

1. Amin AR, Attur MG, Thakker GD, et al. A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases. Proc Natl Acad Sci USA 1996;93:14014-9.
2. Arai I, Konno S, Otani K, Kikuchi S, Olmarker K. Cyclosporin A blocks the toxic effects of nucleus pulposus on spinal nerve roots. Manuscript.
3. Arai I, Mao GP, Otani K, Konno S, Kikuchi S, Olmarker K. Indomethacin blocks nucleus pulposus-related effects in adjacent nerve roots. Spine. In press.
4. Baumgartner RA, Deramo VA, Beaven MA. Constitutive and inducible mechanisms for synthesis and release of cytokines in immune cell lines. J Immunol 1996;157:4087-93.
5. Bidani A, Heming TA. Effects of lidocaine on cytosolic pH regulation and stimulus-induced effector functions in alveolar macrophages. Lung 1997;175:349-61.
6. Black RA, Rauch CT, Kozlosky CJ, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 1997;385:729-33.
7. Bluthe RM, Dantzer R, Kelley KW. Interleukin-1 mediates behavioural but not metabolic effects of tumor necrosis factor alpha in mice. Eur J Pharmacol 1991;209:281-3.
8. Brattsand R, Linden M. Cytokine modulation by glucocorticoids: Mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996;10:81-90.
9. Byröd G, Otani K, Rydevik B, Olmarker K. Acute increase in endoneural vascular permeability induce by epidural application of nucleus pulposus on spinal nerve roots. Manuscript.
10. Chao CC, Hu S, Ehrlich L, Peterson PK. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: Involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 1995;9:355-65.
11. Dawson J, Hurtenbach U, MacKenzie A. Cyclosporin A inhibits the in vivo production of interleukin-1 beta and tumour necrosis factor alpha, but not interleukin-6, by a T-cell-independent mechanism. Cytokine 1996;8:882-8.
12. DeLeo JA, Colburn RW, Rickman AJ. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res 1997;759:50-7.
13. Gadient RA, Cron KC, Otten U. Interleukin-1 beta and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 1990;117:335-40.
14. Garcia-Vicuna R, Diaz-Gonzalez F, Gonzalez-Alvaro I, et al. Prevention of cytokine-induced changes in leukocyte adhesion receptors by nonsteroidal antiinflammatory drugs from the oxicam family. Arthritis Rheum 1997;40:143-53.
15. Gearing AJ, Beckett P, Christodoulou M, et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994;370:555-7.
16. Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996;156:1-4.
17. Gonzalez E, de la Cruz C, de Nicolas R, Egido J, Herrero-Beaumont G. Long-term effect of nonsteroidal antiinflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis. Agents Actions 1994;41:171-8.
18. Hartung HP, Jung S, Stoll G, et al. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 1992;40:197-210.
19. Hattori A, Iwasaki S, Murase K, et al. Tumor necrosis factor is markedly synergistic with interleukin 1 and interferon-gamma in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett 1994;340:177-80.
20. Herman JH, Sowder WG, Hess EV. Nonsteroidal antiin-flammatory drug modulation of prosthesis pseudomembrane induced bone resorption. J Rheumatol 1994;21:338-43.
21. Iwamoto S, Takeda K. Possible cytotoxic mechanisms of TNF in vitro. Hum Cell 1990;3:107-12.
22. Jurd KM, Stephens CJ, Black MM, Hunt BJ. Endothelial cell activation in cutaneous vasculitis. Clin Exp Dermatol 1996;21:28-32.
23. Kawakami M, Tamaki T, Weinstein JN, Hashizume H, Nishi H, Meller ST. Pathomechanism of pain-related behavior produced by allografts of intervertebral disc in the rat. Spine 1996;21:2101-7.
24. Kayama S, Konno S, Olmarker K, Yabuki S, Kikuchi S. Incision of the anulus fibrosus induces nerve root morphologic, vascular, and functional changes: An experimental study. Spine 1996;21:2539-43.
25. Kayama S, Olmarker K, Larsson K, Sjögren-Jansson E, Lindahl A, Rydevik B. Cultured, autologous nucleus pulposus cells induce structural and functional changes in spinal nerve roots. Spine. In press.
26. Kloppenburg M, Brinkman BM, de Rooij-Dijk HH, et al. The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes. Antimicrob Agents Chemother 1996;40:934-40.
27. Kloppenburg M, Verweij CL, Miltenburg AM, et al. The influence of tetracyclines on T cell activation. Clin Exp Immunol 1995;102:635-41.
28. Lamster IB, Pullman JR, Celenti RS, Grbic JT. The effect of tetracycline fiber therapy on beta-glucuronidase and interleukin-1 beta in crevicular fluid. J Clin Periodontol 1996;23:816-22.
29. Liberski PP, Yanagihara R, Nerurkar V, Gajdusek DC. Further ultrastructural studies of lesions produced in the optic nerve by tumor necrosis factor alpha (TNF-alpha): A comparison with experimental Creutzfeldt-Jakob disease. Acta Neurobiol Exp (Warsz) 1994;54:209-18.
30. Lin XH, Kashima Y, Khan M, Heller KB, Gu XZ, Sadun AA. An immunohistochemical study of TNF-alpha in optic nerves from AIDS patients. Curr Eye Res 1997;16:1064-8.
31. Madigan MC, Sadun AA, Rao NS, Dugel PU, Tenhula WN, Gill PS. Tumor necrosis factor-alpha (TNF-alpha)-induced optic neuropathy in rabbits. Neurol Res 1996;18: 176-84.
32. Matsumori A, Ono K, Nishio R, Nose Y, Sasayama S. Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: A possible mechanism for its effect in heart failure. Circulation 1997;96:1386-9.
33. Milano S, Arcoleo F, D'Agostino P, Cillari E. Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrob Agents Chemother 1997;41:117-21.
34. Nawroth P, Handley D, Matsueda G, et al. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med 1988;168:637-47.
35. Oka T, Wakugawa Y, Hosoi M, Oka K, Hori T. Intracerebroventricular injection of tumor necrosis factor-alpha induces thermal hyperalgesia in rats. Neuroimmunomodulation 1996;3:135-40.
36. Olmarker K, Blomquist J, Stromberg J, Nannmark U, Thomsen P, Rydevik B. Inflammatogenic properties of nucleus pulposus. Spine 1995;20:665-9.
37. Olmarker K, Brisby H, Yabuki S, Nordborg C, Rydevik B. The effects of normal, frozen, and hyaluronidase-digested nucleus pulposus on nerve root structure and function. Spine 1997;22:471-5; discussion 476.
38. Olmarker K, Byrod G, Cornefjord M, Nordborg C, Rydevik B. Effects of methylprednisolone on nucleus pulposus-induced nerve root injury. Spine 1994;19:1803-8.
39. Olmarker K, Iwabuchi M, Larsson K, Rydevik B. Effetcs of in vitro degenerated nucleus pulposus on nerve root conduction velocity. Manuscript.
40. Olmarker K, Myers RR. Pathogenesis of sciatic pain: Role of herniated nucleus pulposus and deformation of spinal nerve root and DRG. Pain. In press.
41. Olmarker K, Nordborg C, Larsson K, Rydevik B. Ultrastructural changes in spinal nerve roots induced by autologous nucleus pulposus. Spine 1996;21:411-4.
42. Olmarker K, Rydevik B, Nordborg C. Autologous nucleus pulposus induces neurophysiologic and histologic changes in porcine cauda equina nerve roots [see comments]. Spine 1993; 18:1425-32.
43. Otani K, Arai I, Mao GP, Konno S, Olmarker K, Kikuchi S. Nucleus pulposus-induced nerve root injury: The relationship between blood flow and nerve conduction velocity. Manuscript.
44. Otani K, Mao GP, Arai I, Konno S, Olmarker K, Kikuchi S. Nucleus pulposus-induced increase in vascular permeability in the nerve tool. Manuscript.
45. Petrovich MS, Hsu HY, Gu X, Dugal P, Heller KB, Sadun AA. Pentoxifylline suppression of TNF-alpha mediated axonal degeneration in the rabbit optic nerve. Neurol Res 1997;19: 551-4.
46. Pichler WJ, Zanni M, von Greyerz S, Schnyder B, Mauri-Hellweg D, Wendland T. High IL-5 production by human drug-specific T cell clones. Int Arch Allergy Immunol 1997; 113:177-80.
47. Redfofd EJ, Hall SM, Smith KJ. Vascular changes and demyelination induced by the intraneural injection of tumour necrosis factor. Brain 1995;118:869-78.
48. Robache-Gallea S, Bruneau JM, Robbe H, et al. Partial purification and characterization of a tumor necrosis factor-alpha-converting activity. Eur J Immunol 1997;27:1275-82.
49. Rosendahl MS, Ko SC, Long DL, et al. Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem 1997;272:24588-93.
50. Said G, Hontebeyrie-Joskowicz M. Nerve lesions induced by macrophage activation. Res Immunol 1992;143:589-99.
51. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23:339-46.
52. Shapira L, Houri Y, Barak V, Halabi A, Soskolne WA, Stabholz A. Human monocyte response to cementum extracts from periodontally diseased teeth: Effect of conditioning with tetracycline. J Periodontol 1996;67:682-7.
53. Shapira L, Houri Y, Barak V, Soskolne WA, Halabi A, Stabholz A. Tetracycline inhibits Porphyromonas gingivalis lipopolysaccharide-induced lesions in vivo and TNF alpha processing in vitro. J Periodontal Res 1997;32:183-8.
54. Sharief MK, Ingram DA, Swash M. Circulating tumor necrosis factor-alpha correlates with electrodiagnostic abnormalities in Guillain-Barre syndrome. Ann Neurol 1997;42:68-73.
55. Smith CS, Ortega G, Parker L, Shearer WT. Cyclosporin A blocks induction of tumor necrosis factor-alpha in human B lymphocytes. Biochem Biophys Res Commun 1994;204:383-90.
56. Sommer C, Schmidt C, George A, Toyka KV. A metallo-protease-inhibitor reduces pain associated behavior in mice with experimental neuropathy. Neurosci Lett 1997;237:45-8.
57. Sorkin LS, Xiao WH, Wagner R, Myers RR. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997;81:255-62.
58. Steinmeyer J, Daufeldt S, Taiwo YO. Pharmacological effect of tetracyclines on proteoglycanases from interleukin-1-treated articular cartilage. Biochem Pharmacol 1998;55:93-100.
59. Stoll G, Jung S, Jander S, van der Meide P, Hartung HP. Tumor necrosis factor-alpha in immune-mediated demyelination and Wallerian degeneration of the rat peripheral nervous system. J Neuroinmunol 1993;45:175-82.
60. Takao Y, Mikawa K, Nishina K, Maekawa N, Obara H. Lidocaine attenuates hyperoxic lung injury in rabbits. Acta Anaesthesiol Scand 1996;40:318-25.
61. Teoh KH, Bradley CA, Gauldie J, Burrows H. Steroid inhibition of cytokine-mediated-vasodilation after warm heart surgery. Circulation 1995;92:II347-53.
62. Tsukamoto T, Ishikawa M, Yamamoto T. Suppressive effects of TNF-alpha on myelin formation in vitro. Acta Neurol Scand 1995;91:71-5.
63. van der Poll T, Jansen PM, Van Zee KJ, et al. Tumor necrosis factor-alpha induces activation of coagulation and fibrinolysis in baboons through an exclusive effect on the p55 receptor. Blood 1996;88:922-7.
64. Villarroya H, Violleau K, Ben Younes-Chennoufi A, Baumann N. Myelin-induced experimental allergic encephalomyelitis in Lewis rats: Tumor necrosis factor alpha levels in serum and cerebrospinal fluid immunohistochemical expression in glial cells and macrophages of optic nerve and spinal cord. J Neuroimmunol 1996;64:55-61.
65. Wagner R, Myers RR. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors. Neuroreport 1996;7:2897-901.
66. Wagner R, Myers RR. Schwann cells produce tumor necrosis factor alpha: Expression in injured and non-injured nerves. Neuroscience 1996;73:625-9.
67. Wasaki S, Sakaida I, Uchida K, Kimura T, Kayano K, Okita K. Preventive effect of cyclosporin A on experimentally induced acute liver injury in rats. Liver 1997;17:107-14.
68. Wershil BK, Furuta GT, Lavigne JA, Choudhury AR, Wang ZS, Galli SJ. Dexamethasone and cyclosporin A suppress mast cell-leukocyte cytokine cascades by multiple mechanisms. Int Arch Allergy Immunol 1995;107:323-4.
69. Yabuki S, Kawaguchi Y, Olmarker K, Rydevik B. Effects of lidocain on nucleus pulposus-induced nerve root injury. Spine. In press.
70. Zhu J, Bai XF, Mix E, Link H. Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: Dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin. Clin Immunol Immunopathol 1997;84:85-94.